Description：Rabbit polyclonal antibody to EIF4EImmunogen：KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human EIF4E. The exact sequence is proprietary.Purification：The antibody was purified by immunogen affinity chromatography.Clonality：PolyclonalForm：Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.Dilution：WB (1/500 - 1/1000), IH (1/100 - 1/200)Gene Symbol：EIF4EAlternative Names：EIF4EL1; EIF4F; Eukaryotic translation initiation factor 4E; eIF-4E; eIF4E; eIF-4F 25 kDa subunit; mRNA cap-binding protein Entrez Gene (Human)： 1977; Entrez Gene (Mouse)： 13684; Entrez Gene (Rat)： 117045; SwissProt (Human)： P06730; SwissProt (Mouse)： P63073; SwissProt (Rat)： P63074; Storage/Stability：Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.

• 
  Western blot analysis of EIF4E expression in HEK293T (A), Hela (B), mouse lung (C), mouse kidney (D), rat lung (E), rat kidney (F) whole cell lysates. (Predicted band size: 25 kD; Observed band size: 25 kD)
• 
  Immunohistochemical analysis of EIF4E staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.